Slovakia is giving access to Europe for a Russian antivirus drug
09.04.2010 — News
THE SVERDLOVSK OBLAST
The Slovak Academy of Sciences will certify the antiviral drug Triazavirin for its use in Europe. The unique drug has been developed by the scientists of the Urals Branch of the Russian Academy of Sciences.
The regional government informed RusBusinessNews that Slovakia and the Sverdlovsk Oblast will start working jointly on the production, diagnosis, and certification of several pharmaceuticals. Moreover, cooperation is possible in the production of isotope scanners which enable seeing hard to diagnose cancers at early stages.
|Regions||Project participants||Investment projects||Consulates and Trade Offices||News and Analysis||About the Project|
© RusBusinessNews, 2009.
All rights reserved.
Establishing a hyperlink to RIA RusBusinessNews is required for using any of the material published on this website.
News and analytical reviews are translated into foreign languages by the TRANSLIT Translation Agency
|«Sum of technologies»®